Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (5183)	6/21/1998 4:25:00 PM
From: John Zwiener	Respond to of 9719

Hope you don't mind me pounding the table. Igen, while volatile, is cheap. It is also becoming clearer to me the upside continues to be major. Look at this company again (it took me several times to understand it even though this is my area).

To: Vector1 who wrote (5183)	6/22/1998 6:07:00 AM
From: Rocketman	Respond to of 9719

There is always an attorney to take your money and you can sue for anything......winning is another matter. I told the guy to only do it if the attorney will do it on contingency for a % of the winnings. Especially since the attorney contacted him apparently......must have smelled a sucker and wanted his piece of the action too. Whew! Third time I've heard Tuesday from you, must be serious @;-> Duly noted! Rman

To: Vector1 who wrote (5183)	6/22/1998 6:54:00 AM
From: Rocketman	Read Replies (2) \| Respond to of 9719

According to BioCentury's 6/22/98 issue, the 17% runup in ENMD last week was due to it being proposed to be included in the Russell 3000 index. 11 of 13 biotechs proposed to be added showed gains for the week, while 14 of 19 proposed to be deleted showed losses for the week. They included a table. The final decision on index membership is due out July 7th. "Stocks being added to a high profile stock index often see a temporary price increase and last week was no exception."